Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Rock Creek Pharmaceuticals, Inc. (RCPI) Starts Presentation at LD Micro Invitational Conference

Rock Creek Pharmaceuticals (OTC: RCPI) is an emerging drug development company focused on the discovery, development and commercialization of new drugs, formulations and compounds that provide therapies for chronic and acute inflammatory diseases. The company’s compound is a small molecule, cholinergic agonist that exhibits anti-inflammatory pharmacological characteristics, distinct from other anti-inflammatory drugs. Rock Creek’s lead compound has been investigated extensively in pre-clinical studies resulting in several peer reviewed and published scientific journal articles, covering models of multiple sclerosis, Alzheimer’s disease, and autoimmune thyroiditis. For more information, visit the company’s website at www.rockcreekpharmaceuticals.com

The three-day LD Micro Invitational in Bel Air, California, features company presentations from more than 200 select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies. For more information on LD Micro, visit www.ldmicro.com
This entry was posted in LD Micro Conference. Bookmark the permalink.

Comments are closed.